Skip to content

Study analysing coagulation management before and after the establishment of viscoelastic measurement methods

Study analysing coagulation management before and after the establishment of viscoelastic measurement methods

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038184
Enrollment
50
Registered
2025-11-11
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monitoring of unfractionated heparin during vascular surgery

Interventions

Group 1: Patients undergoing vascular surgery who require unfractionated heparin intraoperatively. Coagulation is measured using an ACT device, ClotPro and standard laboratory tests during the vascula

Sponsors

Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients who undergo surgery at GCH and receive intraoperative UFH with the need for monitoring

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Correlation of ACT clotting time and ClotPro parameters with standard coagulation laboratory (aPPT, calibrated anti-Xa level). Measurements are taken during vascular surgery procedures based on the surgeon's clinical assessment.

Secondary

MeasureTime frame
Change in ACT, ClotPro and standard coagulation laboratory parameters depending on the amount of UFH administered and the time interval.

Countries

Germany

Contacts

Public ContactLars Heubner

Klinik und Poliklinik für Anästhesiologie, Universitätsklinikum Carl Gustav Carus an der TU Dresden

lars.heubner@ukdd.de+4935145811660

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026